rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    VTRS
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Viatris at Jefferies Global Healthcare Conference: growth shift deepens
      18h agoInvesting.comVTRSJEF
      Pacira BioSciences completes merger with Viatris and announces Nasdaq delisting
      Nov 17Investing.comPCRXVTRS
      Are Investors Undervaluing Viatris (VTRS) Right Now?
      Nov 17Yahoo FinanceVTRS
      Viatris Inc. stock falls Thursday, underperforms market
      Nov 12MarketWatchVTRS
      Viatris Named to Fortune's World's Best Workplaces™ List for Second Consecutive Year
      Nov 12Yahoo FinanceVTRS
      Viatris Inc. (VTRS) Hit a 52 Week High, Can the Run Continue?
      Nov 10Yahoo FinanceVTRS
      Viatris (VTRS) Stock May Be Below Fair Value Despite A $1.65B Deal
      Nov 8Yahoo FinanceVTRS
      Earnings Scorecard: 96% healthcare firms post EPS wins this week (PFE:NYSE)
      Nov 7Seeking AlphaVTRS
      Viatris (VTRS) Earnings Beat And Higher Outlook Put Fair Value Back In Focus

      Viatris (VTRS) just posted third quarter 2026 results that beat earnings expectations while revenue came in slightly light, and management raised full year guidance midpoints across key financial metrics, signaling confidence in ongoing operations. The earnings beat, raised guidance and confirmed dividend appear to have fed into a strong run in Viatris. The 30-day share price return of 14.16% and year-to-date share price gain of 59.79% build on a 1-year total shareholder return of 103.71%,...

      Nov 7Yahoo FinanceVTRS
      Are Wall Street Analysts Predicting Viatris Stock Will Climb or Sink?
      Nov 6Yahoo FinanceVTRS
      Jefferies raises Viatris stock price target to $22 on guidance lift
      Nov 6Investing.comVTRS
      Viatris Inc (VTRS) (Q3 2026) Earnings Call Highlights: Raised Guidance, Pacira Deal and Supply ...
      Nov 5Yahoo FinancePCRXVTRS
      Viatris Inc. Q3 2026 Earnings Call Summary
      Nov 5Yahoo FinanceVTRS
      Here's What Key Metrics Tell Us About Viatris (VTRS) Q3 Earnings
      Nov 5Yahoo FinanceVTRS
      Remember Mylan? Its Successor Just Topped A Buy Zone

      Viatris stock topped its buy zone Thursday, shaking off light sales amid enthusiasm for its continued strength in China.

      Nov 5Investor's Business DailyVTRSPFE
      Viatris Q3 2026 Earnings Call Transcript
      Nov 5BenzingaVTRS
      Viatris Q3 Earnings Beat on Stronger Margins, Revenues Fall Y/Y
      Nov 5Yahoo FinanceVTRS
      Viatris (NASDAQ:VTRS) misses Q3 2026 sales expectations but beats adjusted EPS consensus estimates
      Nov 5Yahoo FinanceVTRS
      Viatris post Q3 revenue miss as generics sales drop (VTRS)

      Viatris (VTRS) stock spiked after the company posted a Q3 2026 earnings beat but missed on revenue as generics sales slipped. Read more here.

      Nov 5Seeking AlphaVTRS
      Viatris earnings beat by $0.07, revenue fell short of estimates
      Nov 5Investing.comVTRS
      Viatris beats EPS but misses on revenue, raises guidance
      Nov 5Investing.comVTRS
      Viatris: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceVTRS
      Viatris (VTRS) Q3 Earnings Beat Estimates
      Nov 5Yahoo FinanceVTRS
      Viatris (VTRS) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
      Nov 4Yahoo FinanceVTRS
      Viatris declares $0.12 quarterly dividend per share
      Nov 4Investing.comVTRS
      Viatris Announces Quarterly Dividend
      Nov 4MorningstarVTRS
      Viatris Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

      VTRS heads into Q3 earnings with new product growth, regional sales trends and supply challenges shaping its outlook.

      Nov 3Yahoo FinanceVTRS
      Viatris Inc. stock falls Monday, underperforms market
      Nov 2MarketWatchVTRS
      Viatris Begins $36.50 Per Share Cash Offer for Pacira BioSciences
      Oct 30Yahoo FinancePCRXVTRS
      Viatris launches tender offer for Pacira at $36.50 per share
      Oct 30Investing.comPCRXVTRS
      Viatris Inc. stock rises Thursday, outperforms market
      Oct 29MarketWatchVTRS
      RYZUMVI Approval Could Be A Key Test For Viatris Stock (VTRS)
      Oct 29Yahoo FinanceVTRS
      Viatris (VTRS) Wins FDA Approval For RYZUMVI In Adult Presbyopia
      Oct 28Yahoo FinanceVTRS
      Pacira earnings in focus as Viatris deal nears completion
      Oct 28Investing.comPCRXVTRS
      Viatris Inc. stock rises Tuesday, outperforms market
      Oct 27MarketWatchVTRS
      Viatris stock hits 52-week high at $18.76
      Oct 27Investing.comVTRS
      Will Viatris (VTRS) Beat Estimates Again in Its Next Earnings Report?
      Oct 27Yahoo FinanceVTRS
      Earnings Preview: What to Expect From Viatris' Report
      Oct 27BarchartVTRS
      Viatris Inc. stock rises Monday, outperforms market
      Oct 26MarketWatchVTRS
      Viatris Inc. stock falls Friday, underperforms market
      Oct 23MarketWatchVTRS
      Pacira BioSciences (PCRX) Stock Gets Fair Value Boost After Viatris Deal Framing
      Oct 23Yahoo FinancePCRXVTRS
      Viatris Inc. stock falls Wednesday, underperforms market
      Oct 21MarketWatchVTRS
      A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Viatris (NASDAQ:VTRS) Vs The Rest Of The Pack
      Oct 21Yahoo FinanceVTRS
      JPMorgan Adjusts Viatris Price Target to $20 From $18
      Oct 21Yahoo FinanceVTRS
      Viatris Inc. stock falls Monday, underperforms market
      Oct 19MarketWatchVTRS
      Viatris’ Dividend Has Room to Grow, but Will Management Deliver?
      Oct 19Yahoo FinanceVTRS
      FDA approves Viatris’ Ryzumvi for adult presbyopia
      Oct 19Yahoo FinanceVTRS
      Viatris Inc. stock rises Friday, outperforms market
      Oct 16MarketWatchVTRS
      Viatris receives FDA approval for presbyopia treatment
      Oct 16Investing.comVTRS
      Viatris Gets FDA Approval for Ryzumvi in the Treatment of Presbyopia
      Oct 16Yahoo FinanceVTRS

      This is the newest page. Registered accounts read further back.